Start: 12 Nov 2021, 14:30
End: 12 Nov 2021, 15:45
Speaker: Professor Julia Brown, Leeds Institute of Clinical Trials Research, UK
Speaker: Professor Anthony Chalmers, University of Glasgow
Speaker: Professor Nick Lemoine, NIHR Clinical Research Network, UK
Speaker: Ms Gillian Murphy, NCRI Consumer Forum Member, UK
Speaker: Dr Kirsty Wydenbach, Medicines and Healthcare products Regulatory Agency, UK
Cancer clinical trials have pioneered innovation across UK clinical research with the development of adaptive, platform and precision-medicine oriented trials. The government has recently published its vision for the Future of UK Clinical Research and it is opportune for trialists (clinical, methodologists, trial managers) to take a strategic look at aspects most relevant to cancer, and to recognize opportunities and challenges. Such discussions can inform subsequent consensus work to revolutionize our ambition across cancer disease-types, embed technology, innovation and data integration, and avoid duplication of effort. They can also be used to future-proof trials against pandemic-related disruption, all whilst embracing the desired patient-centered approach. This session will provide an opportunity to hear from different stakeholders, and to provide your own contribution to help define the future vision for UK cancer trials.